메뉴 건너뛰기




Volumn 26, Issue 4, 2014, Pages 314-321

Chemotherapy in the treatment of metastatic, persistent, and recurrent cervical cancer

Author keywords

Cervical cancer; Chemotherapy; Nonplatinum doublets

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; MITOLACTOL; MITOMYCIN; NAVELBINE; OXALIPLATIN; PACLITAXEL; PEMETREXED; TOPOTECAN; VINBLASTINE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; GEMCITABINE; MONOCLONAL ANTIBODY; TAXOID;

EID: 84904052981     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0000000000000042     Document Type: Review
Times cited : (56)

References (39)
  • 4
    • 0019408691 scopus 로고
    • Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase II study of the gynecologic oncology group
    • Thigpen T, Shingleton H, Homesley H, et al. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Cancer 1981; 48:899-903.
    • (1981) Cancer , vol.48 , pp. 899-903
    • Thigpen, T.1    Shingleton, H.2    Homesley, H.3
  • 5
    • 0021793908 scopus 로고    scopus 로고
    • Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: A gynecologic oncology group study
    • Bonomi P, Blessing JA, Stehman FB, et al. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1985; 3:1079-1085.
    • J Clin Oncol , vol.3 , pp. 1079-1085
    • Bonomi, P.1    Blessing, J.A.2    Stehman, F.B.3
  • 6
    • 0024747607 scopus 로고
    • A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: A gynecologic onology group study
    • McGuire WP 3rd, Arseneau J, Blessing JA, et al. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol 1989; 7:1462-1468.
    • (1989) J Clin Oncol , vol.7 , pp. 1462-1468
    • McGuire III, W.P.1    Arseneau, J.2    Blessing, J.A.3
  • 7
    • 0037486920 scopus 로고    scopus 로고
    • Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: A gynecologic oncology group study
    • Fracasso PM, Blessing JA, Wolf J, et al. Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol 2003; 90:177-180.
    • (2003) Gynecol Oncol , vol.90 , pp. 177-180
    • Fracasso, P.M.1    Blessing, J.A.2    Wolf, J.3
  • 8
    • 0029041394 scopus 로고
    • Phase II trial of mitomycin-C in squamous cell carcinoma of the uterine cervix: A gynecologic oncology group study
    • Thigpen T, Blessing JA, Gallup DG, et al. Phase II trial of mitomycin-C in squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1995; 57:376-379.
    • (1995) Gynecol Oncol , vol.57 , pp. 376-379
    • Thigpen, T.1    Blessing, J.A.2    Gallup, D.G.3
  • 9
    • 0024450677 scopus 로고
    • Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix
    • A Gynecologic Oncology Group study
    • Sutton GP, Blessing JA, Adcock L, et al. Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix. A Gynecologic Oncology Group study. Invest New Drugs 1989; 7:341-343.
    • (1989) Invest New Drugs , vol.7 , pp. 341-343
    • Sutton, G.P.1    Blessing, J.A.2    Adcock, L.3
  • 10
    • 0032168956 scopus 로고    scopus 로고
    • A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: A gynecologic oncology group study
    • Look KY, Blessing JA, Levenback C, et al. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol 1998; 70:334-338.
    • (1998) Gynecol Oncol , vol.70 , pp. 334-338
    • Look, K.Y.1    Blessing, J.A.2    Levenback, C.3
  • 11
    • 0033959650 scopus 로고    scopus 로고
    • Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: A Phase II study of the gynecologic oncology group
    • Schilder RJ, Blessing JA, Morgan M, et al. Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group. Gynecol Oncol 2000; 76:204-207.
    • (2000) Gynecol Oncol , vol.76 , pp. 204-207
    • Schilder, R.J.1    Blessing, J.A.2    Morgan, M.3
  • 12
    • 0034089496 scopus 로고    scopus 로고
    • Topotecan in squamous cell carcinoma of the cervix: A phase ii study of the gynecologic oncology group
    • Bookman MA, Blessing JA, Hanjani P, et al. Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group. Gynecol Oncol 2000; 77:446-449.
    • (2000) Gynecol Oncol , vol.77 , pp. 446-449
    • Bookman, M.A.1    Blessing, J.A.2    Hanjani, P.3
  • 13
    • 0035281646 scopus 로고    scopus 로고
    • Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: A gynecologic oncology group study
    • Curtin JP, Blessing JA, Webster KD, et al. Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2001; 19:1275-1278.
    • (2001) J Clin Oncol , vol.19 , pp. 1275-1278
    • Curtin, J.P.1    Blessing, J.A.2    Webster, K.D.3
  • 14
    • 0029865737 scopus 로고    scopus 로고
    • Paclitaxel has moderate activity in squamous cervix cancer. A gynecologic oncology group study
    • McGuire WP, Blessing JA, Moore D, et al. Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. J Clin Oncol 1996; 14:792-795.
    • (1996) J Clin Oncol , vol.14 , pp. 792-795
    • McGuire, W.P.1    Blessing, J.A.2    Moore, D.3
  • 15
    • 34548437625 scopus 로고    scopus 로고
    • Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: A gynecologic oncology group study
    • Garcia AA, Blessing JA, Vaccarello L, Roman LD. Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. Am J Clin Oncol 2007; 30:428-431.
    • (2007) Am J Clin Oncol , vol.30 , pp. 428-431
    • Garcia, A.A.1    Blessing, J.A.2    Vaccarello, L.3    Roman, L.D.4
  • 16
    • 10044278053 scopus 로고    scopus 로고
    • Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: A gynecologic oncology group study
    • Muggia FM., Blessing JA., Waggoner S., et al. Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: A gynecologic oncology group study. Gynecol Oncol. 2005, 96, 108-111.
    • (2005) Gynecol Oncol , vol.96 , pp. 108-111
    • Muggia, F.M.1    Blessing, J.A.2    Waggoner, S.3
  • 17
    • 28044461278 scopus 로고    scopus 로고
    • Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer
    • Tewari KS, Monk BJ. Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer. Curr Oncol Rep 2005; 7:419-434.
    • (2005) Curr Oncol Rep , vol.7 , pp. 419-434
    • Tewari, K.S.1    Monk, B.J.2
  • 18
    • 0031023552 scopus 로고    scopus 로고
    • Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: A gynecologic oncology group study
    • Omura GA, Blessing JA, Vaccarello L, et al. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1997; 15:165-171.
    • (1997) J Clin Oncol , vol.15 , pp. 165-171
    • Omura, G.A.1    Blessing, J.A.2    Vaccarello, L.3
  • 19
    • 0036534291 scopus 로고    scopus 로고
    • Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: A gynecologic oncology group study
    • Bloss JD, Blessing JA, Behrens BC, et al. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2002; 20:1832-1837.
    • (2002) J Clin Oncol , vol.20 , pp. 1832-1837
    • Bloss, J.D.1    Blessing, J.A.2    Behrens, B.C.3
  • 20
    • 4143135504 scopus 로고    scopus 로고
    • Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A gynecologic oncology group study
    • Moore DH, Blessing JA, McQuellon RP, et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2004; 22:3113-3119.
    • (2004) J Clin Oncol , vol.22 , pp. 3113-3119
    • Moore, D.H.1    Blessing, J.A.2    McQuellon, R.P.3
  • 21
    • 23044495279 scopus 로고    scopus 로고
    • Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: A gynecologic oncology group study
    • Long HJ 3rd, Bundy BN, Grendys EC Jr, et al. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2005; 23:4626-4633.
    • (2005) J Clin Oncol , vol.23 , pp. 4626-4633
    • Long III, H.J.1    Bundy, B.N.2    Grendys Jr., E.C.3
  • 22
    • 0035025316 scopus 로고    scopus 로고
    • A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: A gynecologic oncology group study
    • Muderspach LI, Blessing JA, Levenback C, Moore JL Jr. A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol 2001; 81:213-215.
    • (2001) Gynecol Oncol , vol.81 , pp. 213-215
    • Muderspach, L.I.1    Blessing, J.A.2    Levenback, C.3    Moore Jr., J.L.4
  • 23
    • 0030953995 scopus 로고    scopus 로고
    • A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix
    • Papadimitriou CA, Dimopoulos MA, Giannakoulis N, et al. A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix. Cancer 1997; 79:2391-2395.
    • (1997) Cancer , vol.79 , pp. 2391-2395
    • Papadimitriou, C.A.1    Dimopoulos, M.A.2    Giannakoulis, N.3
  • 24
    • 23044471142 scopus 로고    scopus 로고
    • Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: A gynecologic oncology group study
    • Monk BJ, Huang HQ, Cella D, Long HJ 3rd. Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2005; 23:4617-4625.
    • (2005) J Clin Oncol , vol.23 , pp. 4617-4625
    • Monk, B.J.1    Huang, H.Q.2    Cella, D.3    Long III, H.J.4
  • 25
    • 70350433286 scopus 로고    scopus 로고
    • Phase III trial of four cisplatincontaining doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: A gynecologic oncology group study
    • Monk BJ, Sill MW, McMeekin DS, et al. Phase III trial of four cisplatincontaining doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2009; 27:4649-4655.
    • (2009) J Clin Oncol , vol.27 , pp. 4649-4655
    • Monk, B.J.1    Sill, M.W.2    McMeekin, D.S.3
  • 26
    • 78149359590 scopus 로고    scopus 로고
    • Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: A gynecologic oncology group study
    • Cella D, Huang HQ, Monk BJ, et al. Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol 2010; 119:531-537.
    • (2010) Gynecol Oncol , vol.119 , pp. 531-537
    • Cella, D.1    Huang, H.Q.2    Monk, B.J.3
  • 27
    • 74949119951 scopus 로고    scopus 로고
    • A phase III trial of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in stage IVB, persistent or recurrent cervical cancer
    • Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)
    • Saito I, Kitagawa R, Fukuda H, et al. A phase III trial of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in stage IVB, persistent or recurrent cervical cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505). Jpn J Clin Oncol 2010; 40:90-93.
    • (2010) Jpn J Clin Oncol , vol.40 , pp. 90-93
    • Saito, I.1    Kitagawa, R.2    Fukuda, H.3
  • 28
    • 70749125099 scopus 로고    scopus 로고
    • Prognostic factors for response to cisplatinbased chemotherapy in advanced cervical carcinoma: A gynecologic oncology group study
    • Moore DH, Tian C, Monk BJ, et al. Prognostic factors for response to cisplatinbased chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol 2010; 116:44-49.
    • (2010) Gynecol Oncol , vol.116 , pp. 44-49
    • Moore, D.H.1    Tian, C.2    Monk, B.J.3
  • 29
    • 62949142263 scopus 로고    scopus 로고
    • Recent achievements and future developments in advanced and recurrent cervical cancer: Trials of the gynecologic oncology group
    • Tewari KS, Monk BJ. Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group. Semin Oncol 2009; 36:170-180.
    • (2009) Semin Oncol , vol.36 , pp. 170-180
    • Tewari, K.S.1    Monk, B.J.2
  • 30
    • 0033561333 scopus 로고    scopus 로고
    • Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
    • Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340:1144-1153.
    • (1999) N Engl J Med , vol.340 , pp. 1144-1153
    • Rose, P.G.1    Bundy, B.N.2    Watkins, E.B.3
  • 31
    • 77749237017 scopus 로고    scopus 로고
    • The rationale for the use of nonplatinum chemotherapy doublets for metastatic and recurrent cervical carcinoma
    • Tewari KS, Monk BJ. The rationale for the use of nonplatinum chemotherapy doublets for metastatic and recurrent cervical carcinoma. Clin Adv Hematol Oncol 2010; 8:108-115.
    • (2010) Clin Adv Hematol Oncol , vol.8 , pp. 108-115
    • Tewari, K.S.1    Monk, B.J.2
  • 32
    • 70350786938 scopus 로고    scopus 로고
    • Beyond platinum for metastatic and recurrent carcinoma of the cervix
    • Tewari KS, Monk BJ. Beyond platinum for metastatic and recurrent carcinoma of the cervix. Onkologie 2009; 32:552-554.
    • (2009) Onkologie , vol.32 , pp. 552-554
    • Tewari, K.S.1    Monk, B.J.2
  • 33
    • 80052604393 scopus 로고    scopus 로고
    • SCOTCERV: A phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer
    • Symonds RP, Davidson SE, Chan S, et al. SCOTCERV: a phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer. Gynecol Oncol 2011; 123:105-109.
    • (2011) Gynecol Oncol , vol.123 , pp. 105-109
    • Symonds, R.P.1    Davidson, S.E.2    Chan, S.3
  • 34
    • 0034884282 scopus 로고    scopus 로고
    • Synergistic interaction between topotecan and microtubule-interfering agents
    • Bahadori HR, Green MR, Catapano CV. Synergistic interaction between topotecan and microtubule-interfering agents. Cancer Chemother Pharmacol 2001; 48:188-196.
    • (2001) Cancer Chemother Pharmacol , vol.48 , pp. 188-196
    • Bahadori, H.R.1    Green, M.R.2    Catapano, C.V.3
  • 35
    • 4344663407 scopus 로고    scopus 로고
    • Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: A phase I/II study
    • Stathopoulos GP, Rigatos SK, Christodoulou C, et al. Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study. Cancer Chemother Pharmacol 2004; 54:259-264.
    • (2004) Cancer Chemother Pharmacol , vol.54 , pp. 259-264
    • Stathopoulos, G.P.1    Rigatos, S.K.2    Christodoulou, C.3
  • 36
    • 0842288949 scopus 로고    scopus 로고
    • Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma
    • Tiersten AD, Selleck MJ, Hershman DL, et al. Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma. Gynecol Oncol 2004; 92:635-638.
    • (2004) Gynecol Oncol , vol.92 , pp. 635-638
    • Tiersten, A.D.1    Selleck, M.J.2    Hershman, D.L.3
  • 37
    • 0037285662 scopus 로고    scopus 로고
    • Phase i study of paclitaxel and topotecan for the first-line treatment of extensive-stage small cell lung cancer
    • West W, Birch R, Schnell F, et al. Phase I study of paclitaxel and topotecan for the first-line treatment of extensive-stage small cell lung cancer. Oncologist 2003; 8:76-82.
    • (2003) Oncologist , vol.8 , pp. 76-82
    • West, W.1    Birch, R.2    Schnell, F.3
  • 38
    • 84894207820 scopus 로고    scopus 로고
    • Improved survival with bevacizumab in advanced cervical cancer
    • Tewari KS, Sill MW,Long HJ 3rd, et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med 2014; 370:734-743.
    • (2014) N Engl J Med , vol.370 , pp. 734-743
    • Tewari, K.S.1    Sill Mwlong III, H.J.2
  • 39
    • 84906819213 scopus 로고    scopus 로고
    • A limited access phase II trial of pemetrexed in combination with cisplatin in the treatment of advanced, persistent, or recurrent carcioma of the cervix
    • in press
    • Miller DS, Blessing JA, Ramondetta LM, et al. A limited access phase II trial of pemetrexed in combination with cisplatin in the treatment of advanced, persistent, or recurrent carcioma of the cervix. J Clin Oncol 2014. (in press).
    • (2014) J Clin Oncol
    • Miller, D.S.1    Blessing, J.A.2    Ramondetta, L.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.